Skip to main content
. 2016 Jun 15;11(6):e0156747. doi: 10.1371/journal.pone.0156747

Fig 2. Weekly sero-conversion (%) showing the results of MDA regression profiles and post vaccination immune responses in different experimental groups*.

Fig 2

Weekly Mean Sero-conversion (%) measured using (2a) (A/Chicken/Mexico/232/1994) H5N2/Ag indicating MDA regression; (2b) (A/Swan/Hungary/4999/2006)rHVT-H5/Ag indicating immune response to rHVT-H5 vaccination; (2c) (A/Chicken/Egypt/Q1995D/2010)H5N1/Ag indicating immune response to KVT-H5 vaccination; (2d) (A/H5N1/Chicken/Egypt/128s/2012)C/H5N1/Ag indicating immune response to challenge virus antigen. *Group I (vaccinated with rHVT-H5 vaccine at 1 day old), Group II (vaccinated with inactivated MEFLUVAC-H5 vaccine at 8 days old), Group III (unvaccinated control).